COFCO Biotechnology Co., Ltd. (000930.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap10.69B
Enterprise Value10.6B
P/E Ratio-40.22
PEG Ratio0.37
Price/Sales Ratio0.57
Price/Book Ratio0.93
Enterprise/Revenue0.76
Enterprise/EBITDA61.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.01
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue17.51B
Revenue/Share9.1
Gross Profit1.46B
EBITDA684.99M
Net Income38.37M
Diluted EPS0.02

Balance Sheet

Total Cash2.13B
Total Cash/Share1.15
Total Debt5.44B
Total Debt/Equity0.53
Current Ratio1.27
Book Value Per Share5.82

Price History

52-Week Change-13.57
52-Week High8.14
52-Week Low4.24
Moving Average 50 Days5.02
Moving Average 200 Days5.71

Statistics

Average Volume42.06M
Shares Outstanding1.86B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.58
Payout Ratio-0.39
Last Split Factor2:1
Last Split DateDecember 07, 2005
AD